Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.

PHASE3CompletedINTERVENTIONAL
Enrollment

431

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Cocculine®

12 tablets in 3 days at each of the CT courses: 2 on the day before evening of the CT courses; 2 on the morning, noon and evening of the CT courses; 2 on morning and noon of the day after the CT courses.

DRUG

placebo

12 tablets in 3 days at each of the CT courses: 2 on the day before evening of the CT courses; 2 on the morning, noon and evening of the CT courses; 2 on morning and noon of the day after the CT courses.

Trial Locations (1)

69000

Centre Leon Berard, Lyon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BOIRON

INDUSTRY

lead

Centre Leon Berard

OTHER

NCT00409071 - Placebo-controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer. | Biotech Hunter | Biotech Hunter